Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	95
Overall Study	STARTED	GEn 1200 mg/Day	107
Overall Study	STARTED	GEn 2400 mg/Day	84
Overall Study	STARTED	GEn 3600 mg/Day	90
Overall Study	Intent-to-Treat Population	Placebo	95
Overall Study	Intent-to-Treat Population	GEn 1200 mg/Day	107
Overall Study	Intent-to-Treat Population	GEn 2400 mg/Day	82
Overall Study	Intent-to-Treat Population	GEn 3600 mg/Day	87
Overall Study	Safety Population	Placebo	95
Overall Study	Safety Population	GEn 1200 mg/Day	107
Overall Study	Safety Population	GEn 2400 mg/Day	82
Overall Study	Safety Population	GEn 3600 mg/Day	87
Overall Study	COMPLETED	Placebo	64
Overall Study	COMPLETED	GEn 1200 mg/Day	85
Overall Study	COMPLETED	GEn 2400 mg/Day	60
Overall Study	COMPLETED	GEn 3600 mg/Day	56
Overall Study	NOT COMPLETED	Placebo	31
Overall Study	NOT COMPLETED	GEn 1200 mg/Day	22
Overall Study	NOT COMPLETED	GEn 2400 mg/Day	24
Overall Study	NOT COMPLETED	GEn 3600 mg/Day	34

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00619476/flow